FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:566-567 February 24, 1994 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Patients with venous thromboembolism can be divided into two groups. The first includes patients with a disease such as cancer, a predisposing factor such as recent surgery, or an acquired abnormality such as the lupus anticoagulant that is known to increase the risk of thrombosis. The mechanisms underlying the hypercoagulable state in this group are poorly understood. The second category consists of patients without the usual risk factors that predispose people to venous thrombosis. In some of these patients it is possible to identify a deficiency of antithrombin III, protein C, or protein S. Family studies have shown that hereditary . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Dacosta, A, Tardy-Poncet, B, Isaaz, K, Cerisier, A, Mismetti, P, Simitsidis, S, Reynaud, J, Tardy, B, Piot, M, Decousus, H, Guyotat, D (1998). Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart 80: 338-340 [Abstract] [Full Text]